Introduction Securing a WDA licence is often treated as the finish line. In reality, it is the point at which the real compliance burden begins. Approval confirms that the licensing authority was satisfied at the time of assessment, but it does not reduce the organisation’s obligations after…

Introduction One of the most common mistakes in WDA planning is assuming that cost is mainly about the application fee and that timing is mainly about how fast a form can be submitted. Both assumptions are wrong. In reality, the true cost of obtaining a WDA licence includes regulatory fees, in…

Introduction In pharmaceutical trade, credibility is rarely created by marketing alone. It is created by the ability to move regulated products through regulated channels without compromising quality, traceability, or legal control. That is why a Wholesale Dealer Authorisation matters far beyo…

Introduction For any pharmaceutical business that intends to buy, sell, hold, or supply medicines within the UK wholesale chain, the Wholesale Dealer Authorisation is not a formality. It is one of the clearest regulatory tests of whether a company is operationally credible, commercially seriou…

Computer system validation is entering a new phase. The established principles of intended use, documented evidence, lifecycle control, and risk-based assurance remain central, but the environments in which those principles must operate are changing rapidly. Cloud-hosted platforms, configurable …

Computer system validation projects succeed when organisations apply structure, judgement, and lifecycle control in a way that reflects real operational risk. GAMP 5 has become one of the most influential frameworks for achieving that balance. It is not a regulation, and it does not replace lega…